Early research (Phase 1)Study completedNCT02048787What this trial is testingPharmacokinetic Study of Buparlisib in Subjects With Renal Impairment.Who this might be right forRenal Impairment Novartis Pharmaceuticals 19
Not applicableStudy completedNCT01721837What this trial is testingDabigatran Etexilate for Stroke Prevention in Patients With Atrial Fibrillation and Mild to Moderate Renal ImpairmentWho this might be right forAtrial Fibrillation Boehringer Ingelheim 4,340
Early research (Phase 1)Study completedNCT01442259What this trial is testingAn Open-label, Parallel-group Study to Determine the Pharmacokinetics of a Single Dose of AFQ056 in Subjects With Renal Impairment Compared to Healthy SubjectsWho this might be right forMild Moderateor Severe Renal Impairment Novartis Pharmaceuticals 48
Early research (Phase 1)Ended earlyNCT00984113What this trial is testingPharmacokinetics of Elinogrel in Healthy Volunteers and Patients With Mild, Moderate, and Severe Renal ImpairmentWho this might be right forRenal Impairment Portola Pharmaceuticals 44
Testing effectiveness (Phase 2)Study completedNCT02448628What this trial is testingExploratory Study of CS-3150 in Japanese Hypertensive Patients With Moderate Renal ImpairmentWho this might be right forHypertension Daiichi Sankyo 33
Large-scale testing (Phase 3)Study completedNCT03422653What this trial is testingEvaluate the Safety and Efficacy of CR845 in Hemodialysis Patients With Moderate-to-Severe Pruritus (KALM-1)Who this might be right forUremic Pruritus Cara Therapeutics, Inc. 378
Early research (Phase 1)Study completedNCT05895812What this trial is testingA Study in Subjects With Renal Impairment Compared to Subjects With Normal Renal FunctionWho this might be right forSubjects With Renal ImpairmentHealthy Subjects Shanghai Vinnerna Biosciences Co., Ltd. 24
Large-scale testing (Phase 3)Study completedNCT01363011What this trial is testingCobicistat-containing Highly Active Antiretroviral Regimens in HIV-1 Infected Patients With Mild to Moderate Renal ImpairmentWho this might be right forAcquired Immunodeficiency SyndromeHIV Infections Gilead Sciences 106
Early research (Phase 1)Study completedNCT02674581What this trial is testingThe Pharmacokinetics and Safety of BMS-663068 Administered in Subjects With Normal Renal Function and With Mild, Moderate, Severe and End Stage Renal Dysfunction (ESRD)Who this might be right forHIV Infections ViiV Healthcare 30
Not applicableActive Not RecruitingNCT06652100What this trial is testingEstablishment of ProNephro AKI (NGAL) Cut Off Value for Risk Assessment of Moderate to Severe Acute Kidney Injury in AdultsWho this might be right forAcute Kidney Injury BioPorto Diagnostics 800
Early research (Phase 1)Study completedNCT01674192What this trial is testingPrucalopride Subjects With Renal ImpairmentWho this might be right forConstipation Movetis 34
Early research (Phase 1)Study completedNCT05368935What this trial is testingNitazoxanide Pharmacokinetic Parameters in Renal Impaired SubjectsWho this might be right forRenal ImpairmentRenal DiseaseKidney Disease Genfit 77
Large-scale testing (Phase 3)Ended earlyNCT03315143What this trial is testingEffect of Sotagliflozin on Cardiovascular and Renal Events in Participants With Type 2 Diabetes and Moderate Renal Impairment Who Are at Cardiovascular RiskWho this might be right forHeart FailureType 2 Diabetes MellitusChronic Kidney Diseases Lexicon Pharmaceuticals 10,584
Large-scale testing (Phase 3)Ended earlyNCT05356403What this trial is testingCR845-310302: A Study to Evaluate the Safety and Efficacy of Difelikefalin in Advanced Chronic Kidney Disease Patients With Moderate-to-Severe PruritusWho this might be right forChronic Kidney DiseasesPruritus Cara Therapeutics, Inc. 105
Early research (Phase 1)Study completedNCT01894256What this trial is testingStudy to Assess the Blood Levels and Safety of Olaparib in Patients With Advanced Solid Tumours and Normal or Impaired Kidney FunctionWho this might be right forSolid Tumours AstraZeneca 56
Large-scale testing (Phase 3)Study completedNCT00646542What this trial is testingSafety and Tolerability of Vildagliptin Versus Placebo in Patients With Type 2 Diabetes and Moderate or Severe Renal InsufficiencyWho this might be right forDiabetes Mellitus, Type 2 Novartis 525
Early research (Phase 1)Study completedNCT01459250What this trial is testingPharmacokinetics, Safety and Tolerability of AGO178C in Subjects With Renal Deficiencies Compared With Healthy SubjectsWho this might be right forRenal Impairment Novartis Pharmaceuticals 32
Early research (Phase 1)Study completedNCT00887627What this trial is testingStudy to Compare Conivaptan Pharmacokinetics in Subjects With Mild & Moderate Kidney Function Impairment to Subjects With Normal Kidney FunctionWho this might be right forKidney DiseasesHyponatremia Cumberland Pharmaceuticals 25
Early research (Phase 1)Study completedNCT02320045What this trial is testingStudy to Evaluate Pharmacokinetics of ITCA 650 in Subjects With Renal Impairment Compared to Normal SubjectsWho this might be right forRenal Insufficiency Intarcia Therapeutics 38
Early research (Phase 1)Study completedNCT02108639What this trial is testingTo Assess the Effect of Renal Impairment on the Blood Levels of Daclatasvir (DCV), Asunaprevir (ASV) and BMS-791325 After Multiple Doses of a Fixed Dose Combination TabletWho this might be right forHepatitis C Bristol-Myers Squibb 41